Ocular Therapeutix (OCUL)

Ocular Therapeutix (OCUL) – FDA

Apr 18, 2024 07:01 AM Ocular Therapeutix (OCUL) Reports Positive Topline Phase 1 Data for AXPAXLI
Jan 25, 2024 08:01 AM Ocular Therapeutix (OCUL) Announces FDA Agreement to Amend Special Protocol Assessment for Trial of AXPAXLI
Nov 1, 2023 08:02 AM
Oct 31, 2023 09:04 AM
Jun 12, 2023 05:28 AM
Feb 13, 2023 05:45 AM
Dec 12, 2022 06:38 AM
Sep 27, 2022 06:00 AM
Apr 13, 2022 05:38 AM
Dec 6, 2021 07:02 AM
Nov 5, 2021 09:01 AM
Oct 22, 2021 08:01 AM
Oct 11, 2021 12:31 PM
Aug 5, 2021 06:05 PM
Jun 29, 2021 08:02 AM
Mar 4, 2021 04:02 PM
Mar 1, 2021 07:16 AM
Jan 20, 2021 08:01 AM
Dec 22, 2020 08:46 AM
Oct 8, 2020 08:03 AM
Sep 29, 2020 08:03 AM
Sep 10, 2020 07:03 AM
May 12, 2020 07:13 AM
Apr 28, 2020 07:07 AM
Feb 7, 2020 08:03 AM
Oct 1, 2019 04:24 PM
Sep 24, 2019 08:08 AM
Jul 1, 2019 08:01 AM
Jun 21, 2019 08:01 AM
May 20, 2019 04:07 PM
May 1, 2019 08:34 AM
Apr 2, 2019 08:16 AM
Feb 20, 2019 08:33 AM
Jan 10, 2019 04:02 PM
Dec 3, 2018 07:01 AM
Oct 19, 2018 07:50 AM
Jul 19, 2018 08:06 AM
Jun 29, 2018 08:00 AM
May 3, 2018 04:50 PM
Dec 22, 2017 04:12 PM
Jul 11, 2017 05:02 PM
Jul 10, 2017 04:16 PM
Jul 7, 2017 03:29 PM
May 11, 2017 08:10 AM
May 9, 2017 02:50 PM
May 8, 2017 08:10 AM
Apr 24, 2017 12:35 PM
Mar 15, 2017 08:12 AM
Mar 13, 2017 07:38 AM
Mar 10, 2017 07:34 AM